199 related articles for article (PubMed ID: 12753532)
1. Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis.
Ayad MS; Knight KR; Burdon JG; Brenton S
Respirology; 2003 Jun; 8(2):175-80. PubMed ID: 12753532
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
[TBL] [Abstract][Full Text] [Related]
3. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema.
Knight KR; Burdon JG; Cook L; Brenton S; Ayad M; Janus ED
Respirology; 1997 Jun; 2(2):91-5. PubMed ID: 9441132
[TBL] [Abstract][Full Text] [Related]
4. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
[TBL] [Abstract][Full Text] [Related]
5. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
6. Role of secretory leukocyte protease inhibitor in the development of subclinical emphysema.
Betsuyaku T; Takeyabu K; Tanino M; Nishimura M
Eur Respir J; 2002 Jun; 19(6):1051-7. PubMed ID: 12108856
[TBL] [Abstract][Full Text] [Related]
7. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
[TBL] [Abstract][Full Text] [Related]
8. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
Westin U; Lundberg E; Wihl JA; Ohlsson K
Allergy; 1999 Aug; 54(8):857-64. PubMed ID: 10485390
[TBL] [Abstract][Full Text] [Related]
9. The proteinase-antiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients.
King MB; Campbell EJ; Gray BH; Hertz MI
Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):966-71. PubMed ID: 8143063
[TBL] [Abstract][Full Text] [Related]
10. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
Sallenave JM; Donnelly SC; Grant IS; Robertson C; Gauldie J; Haslett C
Eur Respir J; 1999 May; 13(5):1029-36. PubMed ID: 10414400
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluticasone on the elastase:antielastase profile of the normal lung.
Kamal AM; Corrigan CJ; Tetley TD; Alaghband-Zadeh J; Smith SF
Eur J Clin Invest; 2002 Sep; 32(9):713-9. PubMed ID: 12486873
[TBL] [Abstract][Full Text] [Related]
13. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
14. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.
Trefz G; Schliesser J; Heck B; Schulz V; Ebert W
Clin Investig; 1992; 70(3-4):269-76. PubMed ID: 1521041
[TBL] [Abstract][Full Text] [Related]
16. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
Kouchi I; Yasuoka S; Ueda Y; Ogura T
Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of alpha-1-antitrypsin phenotypes and genotypes in patients with early-onset pulmonary emphysema].
Dwomiczak S; Ziora D; Konofalski L; Szalaty M; Kowalska A; Kozielski J
Pneumonol Alergol Pol; 2005; 73(1):12-7. PubMed ID: 16539178
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
20. Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia.
Greene C; Taggart C; Lowe G; Gallagher P; McElvaney N; O'Neill S
J Infect Dis; 2003 Sep; 188(5):769-76. PubMed ID: 12934194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
